280 related articles for article (PubMed ID: 20960524)
1. Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50".
Andriole GL; Kibel AS
Cancer; 2011 Mar; 117(6):1110-2. PubMed ID: 20960524
[No Abstract] [Full Text] [Related]
2. Screening for prostate cancer: growth without control.
Eisinger F; Blay JY; Pivot X; Morère JF; Coscas Y; Calazel-Benque A; Roussel C; Viguier J
Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S33-5. PubMed ID: 21245678
[TBL] [Abstract][Full Text] [Related]
3. [Why am I forbidden from dosing my PSA?].
Nau JY
Rev Med Suisse; 2012 Oct; 8(356):1890-1. PubMed ID: 23133893
[No Abstract] [Full Text] [Related]
4. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
Jackson BR
Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
[No Abstract] [Full Text] [Related]
7. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
[TBL] [Abstract][Full Text] [Related]
8. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
[TBL] [Abstract][Full Text] [Related]
9. [Does a low PSA at 60 years old exclude the risk of developing prostate carcinoma?].
Zürcher S
Rev Med Suisse; 2014 Jun; 10(434):1316. PubMed ID: 25073308
[No Abstract] [Full Text] [Related]
10. Summaries for patients. Screening smarter, not harder, for prostate cancer.
Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056
[No Abstract] [Full Text] [Related]
11. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
Carroll PR; Whitson JM; Cooperberg MR
J Clin Oncol; 2011 Feb; 29(4):345-7. PubMed ID: 21189396
[No Abstract] [Full Text] [Related]
12. PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer.
Otto SJ; Moss SM; Määttänen L; Roobol M; Zappa M; Nelen V; Kwiatkowski M; Villers A; Hugosson J; Sanchez AB; de Koning HJ
Eur J Cancer; 2010 Nov; 46(17):3053-60. PubMed ID: 21047586
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening and mortality: comparison of recent randomized controlled clinical trials.
Mian BM
Urol Oncol; 2010; 28(3):233-6. PubMed ID: 20097584
[No Abstract] [Full Text] [Related]
14. Prostate-specific antigen dynamics and prostate cancer diagnosis.
Bartoletti R
Eur Urol; 2009 Nov; 56(5):761-2; discussion 763. PubMed ID: 19665286
[No Abstract] [Full Text] [Related]
15. Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.
Matikainen MP; Schleutker J; Mörsky P; Kallioniemi OP; Tammela TL
Clin Cancer Res; 1999 Jun; 5(6):1275-9. PubMed ID: 10389909
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen: a new(ish) study.
Harv Mens Health Watch; 2010 Nov; 15(4):6-8. PubMed ID: 21166115
[No Abstract] [Full Text] [Related]
17. Prostate-specific antigen levels and subsequent prostate cancer: potential for screening.
Helzlsouer KJ; Newby J; Comstock GW
Cancer Epidemiol Biomarkers Prev; 1992; 1(7):537-40. PubMed ID: 1284590
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the prostate: overview of the most common malignancy in men.
Carson CC
N C Med J; 2006; 67(2):122-7. PubMed ID: 16752715
[No Abstract] [Full Text] [Related]
19. In this issue: mini-theme on geriatric care and cancer screening.
Bowman MA; Neale AV
J Am Board Fam Med; 2009; 22(3):231-3. PubMed ID: 19429726
[No Abstract] [Full Text] [Related]
20. Critical appraisal of prostate-specific antigen in prostate cancer screening: 20 years later.
Pienta KJ
Urology; 2009 May; 73(5 Suppl):S11-20. PubMed ID: 19375622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
